Invasive Aspergillosis Terminated Phase 3 Trials for Isavuconazonium (DB06636)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0031838 (Invasive Aspergillosis) | Terminated | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT04707703 | Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis | Prevention |